Varix is defined as an elongated, dilated, typically tortuous vein reported in the eyelid, conjunctiva, iris, optic disk, and orbit.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] In review of the literature, iris varices have only been described in nine case reports misdiagnosed as capillary hemangiomas, cavernous hemangiomas, and arteriovenous malformations.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\] Consequently, these cases were treated by observation, excision, and laser photocoagulation.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\] In general, iris varices have been thought to be unilateral, solitary, and without systemic associations.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18]\] This study provides the literature with a clinical profile, multimodality imaging findings, disease course, and long-term outcomes of iris varices in 28 eyes.

Methods {#sec1-2}
=======

A retrospective, noncomparative, observational case series was conducted. It adhered to the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act of 1996. Approval was obtained from the Internal Review Board to perform a retrospective chart review. No informed patient consent was required in view of retrospective noninterventional nature of the study. This study was limited to patients with iris varix diagnosed between 2007 and 2017. Thus, 28 eyes of 26 patients were initially diagnosed with iris varix by clinical examination and followed for change. No patients with iris hemangioma or clinically indeterminate vascular iris lesions were included.

Data parameters {#sec2-1}
---------------

The demographic data included age, gender, and associated ocular and systemic diseases. Ophthalmologic examinations were inclusive of, but not limited to, visual acuity with the Early Treatment Diabetic Retinopathy Study charts in Collaborative Ocular Melanoma Study certified rooms, slit-lamp biomicroscopy with photography, tonometry, gonioscopy with photography, dilated indirect ophthalmoscopy, high-frequency ultrasonography (20--50 MHz), and iris fluorescein angiography.

Focused anterior segment examination included noting laterality of the varix, pupil shape, pupillary ruff, quadrant of the iris varix, number of varices, varix orientation (radial, circumferential, combined), associated iris nevus, hyphema, corneal endothelial pigment dusting, and dilated episcleral sentinel blood vessel in the quadrant of the iris varix.

Definitions of orientation {#sec2-2}
--------------------------

**Radial iris varix** defined by a clinically visible portion of the varix was seen traversing from the root of the iris to the pupillary margin in one or more meridians \[[Fig. 1a](#F1){ref-type="fig"}\].**Circumferential iris varix** was defined by a clinically visible portion, running parallel to the pupillary margin \[[Fig. 1b](#F1){ref-type="fig"}\].**Combined iris varix** contained both radial and circumferential components \[[Fig. 1c](#F1){ref-type="fig"}\].

![Photography reveals the visible portions of iris varices: (a) radial varix, (b) circumferential varix, (c) combined varix (radial and circumferential components), (d) nevus in the same meridian as the varix, (e) nevus in same quadrant as the varix, and (f) varices with an episcleral sentinel blood vessel (black arrow)](IJO-67-350-g001){#F1}

**Slit-lamp photography:** Digital imaging was performed in each case. We routinely use side-by-side comparisons over time as a method to screen for change in anterior segment anomalies.\[[@ref19]\] Gonioscopy focused on angle (open, narrow or focal angle closure, pigment dispersion, and bridging blood vessels).

**High-frequency ultrasound imaging:** Longitudinal and transverse images in the central meridian of the varix were recorded. This was followed by a 360° screening of the entire anterior segment. Ultrasonography evaluated for iridociliary angle blunting, maximum iris thickness (meridian of the varix), adjacent ciliary body thickness (meridian of the varix), and iris pigment epithelium (IPE) characteristics (intact, erosion, posterior bowing, or anterior displacement). In addition, iris nodularity was measured and vascular channels were noted. Based on normative values, iris thickness of more than 0.7 mm was considered as increased.\[[@ref20]\]

**Fluorescein angiography:** Intravenous anterior segment angiography was not typically performed. However, when obtained, we observed appearance of hyperfluorescence (early, mid-phase, and late), duration of hyperfluorescence (transient, persistent), and dye leakage.

Follow-up {#sec2-3}
---------

First follow-up examination was performed at 3 months. Subsequent examination included two 6-monthly visits and then at 12-month intervals thereafter. A detailed clinical evaluation, photographic documentation, and high-frequency ultrasound imaging were performed at each visit.

Results {#sec1-3}
=======

Demographics {#sec2-4}
------------

From 2007 to 2017, 26 patients with iris varix were referred for evaluation and treatment. Two were bilateral; therefore, 28 eyes of 26 patients were analyzed in this study. The mean (±SD) age at presentation was 58.3 ± 12.5 years (median 57.5 and range 37--81). There were 57.7% (*n* = 15/26) males and 42.3% (*n* = 11/26) females. All patients in this series were Caucasian. Past medical histories at presentation revealed that 27% (*n* = 7/26) had hypertension. Past ocular history revealed two cases with bilateral treated open angle glaucoma and two bilateral glaucoma suspects \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic and historical characteristics

  Case no.   Age (years)                       Gender                                                Systemic history                                             Ocular history                                          Laterality
  ---------- --------------------------------- ----------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------- ----------------------------------------------------------
  1          70                                M                                                     None                                                         None                                                    Unilateral
  2          50                                M                                                     Hypertension                                                 None                                                    Unilateral
  3          44                                M                                                     None                                                         None                                                    Bilateral
  4          44                                M                                                     None                                                         OU LASIK                                                Unilateral
  5          65                                M                                                     Hypertension                                                 None                                                    Unilateral
  6          47                                F                                                     Heart disease                                                None                                                    Unilateral
  7          51                                M                                                     Diabetes mellitus                                            None                                                    Unilateral
  8          67                                M                                                     None                                                         OU POAG                                                 Unilateral
  9          72                                M                                                     Hypertension                                                 None                                                    Unilateral
  10         47                                M                                                     None                                                         None                                                    Unilateral
  11         81                                M                                                     Urinary bladder cancer, heart disease                        None                                                    Unilateral
  12         70                                M                                                     None                                                         None                                                    Unilateral
  13         73                                F                                                     None                                                         Duane syndrome                                          Unilateral
  14         44                                F                                                     Leukemia                                                     None                                                    Unilateral
  15         77                                F                                                     Hypertension, uterine cancer, heart disease                  None                                                    Unilateral
  16         44                                F                                                     None                                                         None                                                    Unilateral
  17         43                                F                                                     None                                                         None                                                    Unilateral
  18         66                                F                                                     None                                                         OU POAG                                                 Unilateral
  19         60                                M                                                     Ulcerative colitis                                           None                                                    Unilateral
  20         55                                F                                                     Hypertension, breast cancer                                  None                                                    Unilateral
  21         37                                M                                                     None                                                         None                                                    Unilateral
  22         71                                F                                                     Heart disease                                                OU cataract surgery                                     Bilateral
  23         65                                F                                                     Hypothyroid                                                  OU glaucoma suspect                                     Unilateral
  24         53                                M                                                     None                                                         Strabismus surgery                                      Unilateral
  25         50                                M                                                     Hypertension                                                 OU POAG                                                 Unilateral
  26         70                                F                                                     Hypertension                                                 OU glaucoma suspect                                     Unilateral
             Mean age: 58.3 Median age: 57.5   Males: 57.7% (*n*=15/26) Females: 42.3% (*n*=11/26)   Most common systemic illness: Hypertension (*n*=7/26, 27%)   Most common ocular association: POAG (*n*=2/26, 7.7%)   Unilateral: 92.3% (*n*=24/26) Bilateral: 7.7% (*n*=2/26)

M: Male; F: Female; OU=Both eyes; LASIK: Laser-assisted in situ keratomileusis; POAG: Primary open angle glaucoma

Ophthalmic findings {#sec2-5}
-------------------

Mean, median, and range of visual acuity at presentation were 20/20, 20/20, and 20/16--20/40. Visual acuities less than 20/20 (*n* = 2/28) were unrelated to the varices (1 choroidal melanoma and 1 vitelliform macular degeneration). Varices involved the left eye in 68% (*n* = 19/28) resulting in a Chi-square 7.1429 and a significant *P* value of 0.007526 (*P* \< 0.05). There were no relative afferent pupillary defects. No corectopia, ectropion uveae, or hyphema was noted in our series. One eye had bilateral corneal endothelial pigmentation in a case with open angle glaucoma. The mean (±SD), median, and range of initial intraocular pressures were 15.6 (± 2.9), 16, and 10--23 mmHg. No early or late glaucoma could be attributed to a varix in this series. Dilated fundus examination findings are shown in [Table 2](#T2){ref-type="table"}.

###### 

Clinical and varix characteristics

  Eye no.   Eye                                      BCVA               IOP (mmHg)       No. of varix               Location (quadrant)                          Orientation of varix                                 Episcleral sentinel vessel                 Iris nevus                     Fundus
  --------- ---------------------------------------- ------------------ ---------------- -------------------------- -------------------------------------------- ---------------------------------------------------- ------------------------------------------ ------------------------------ ---------------------------------------------
  1         OS                                       20/16              16               2                          STQ                                          Radial                                               No                                         No                             Normal
  2         OS                                       20/20              15               1                          ITQ, STQ                                     Radial                                               Yes                                        No                             Normal
  3         OD                                       20/20              10               1                          ITQ                                          Radial                                               No                                         No                             Normal
  4         OS                                       20/20              10               1                          INQ                                          Radial                                               Yes                                        Yes                            Normal
  5         OS                                       20/16              16               1                          ITQ                                          Circumferential                                      No                                         No                             Normal
  6         OS                                       20/40              17               4                          STQ, ITQ, INQ                                Radial                                               Yes                                        No                             Vitelliform macular dystrophy
  7         OS                                       20/20              18               1                          ITQ                                          Radial                                               No                                         No                             Normal
  8         OD                                       20/25              12               1                          ITQ                                          Combined                                             No                                         No                             Normal
  9         OD                                       20/20              23               1                          ITQ                                          Radial                                               No                                         No                             Normal
  10        OS                                       20/16              17               3                          STQ, ITQ                                     Radial and Circumferential                           No                                         No                             Normal
  11        OD                                       20/16              16               1                          ITQ                                          Circumferential                                      Yes                                        No                             Normal
  12        OS                                       20/25              15               1                          STQ                                          Radial                                               No                                         No                             RPE hypertrophy
  13        OS                                       20/20              13               1                          STQ                                          Combined                                             No                                         No                             Normal
  14        OS                                       20/20              12               2                          STQ                                          Radial                                               Yes                                        No                             Normal
  15        OS                                       20/20              13               1                          STQ                                          Combined                                             No                                         No                             Normal
  16        OS                                       20/40              18               1                          ITQ                                          Combined                                             No                                         No                             Choroidal melanoma
  17        OS                                       20/20              17               1                          ITQ                                          Radial                                               Yes                                        No                             RPE hypertrophy
  18        OS                                       20/16              16               1                          ITQ                                          Circumferential                                      No                                         Yes                            Normal
  19        OS                                       20/20              19               4                          STQ, ITQ, SNQ                                Radial                                               No                                         No                             Choroidal nevus
  20        OS                                       20/16              16               1                          ITQ                                          Circumferential                                      No                                         No                             Normal
  21        OD                                       20/16              14               1                          ITQ                                          Radial                                               No                                         Yes                            Normal
  22        OD                                       20/20              12               2                          ITQ                                          Radial and combined                                  Yes                                        No                             Normal
  23        OD                                       20/25              16               1                          ITQ                                          Circumferential                                      Yes                                        No                             Normal
  24        OS                                       20/20              16               1                          ITQ                                          Circumferential                                      Yes                                        No                             Normal
  25        OS                                       20/20              22               2                          ITQ                                          Radial                                               No                                         No                             Normal
  26        OS                                       20/25              15               2                          STQ, ITQ                                     Radial                                               No                                         No                             Normal
  27        OD                                       20/20              17               2                          ITQ                                          Combined                                             No                                         No                             Normal
  28        OD                                       20/25              15               2                          STQ                                          Radial and Combined                                  Yes                                        No                             Normal
            OD: 32% (*n*=9/28) OS: 68% (*n*=19/28)   Mean BCVA: 20/20   Mean IOP: 15.6   Median number of varix:1   Most common location: ITQ (*n*=21/28, 75%)   Most common orientation: radial (*n*=16/28, 57.1%)   Sentinel blood vessel: 35.7% (*n*=10/28)   Iris nevus: 10.7% (*n*=3/28)   Most common: RPE hypertrophy (*n*=2/28, 7%)

OD: Right eye; OS: Left eye; BCVA: Best-corrected visual acuity; IOP: Intraocular pressure; STQ: Superotemporal quadrant; SNQ: Superonasal quadrant; ITQ: Inferotemporal quadrant; INQ: Inferonasal quadrant; RPE: Retinal pigment epithelium

Varix characteristics {#sec2-6}
---------------------

**Laterality:** Unilateral varices (*n* = 24/26, 92.3%) and bilateral varix (*n* = 2/26, 7.7%)**Number of varices in each eye:** (*n* = 18/28, 64.3%) had a single varix, (*n* = 10/28, 35.7%) contained multiple varices. All circumferential varices and bilateral varices were single**Location (quadrant):** Varices involved one or more iris quadrants. They were most commonly observed in the inferotemporal (*n* = 21/28, 75%) followed by superotemporal (*n* = 11/28, 39.2%). Five eyes (17.9%) had more than 1 quadrant involvement (2 quadrants: *n* = 3/28, 10.7%; and 3 quadrants: *n* = 2/28, 7.1%). Circumferential varices occurred only in the inferotemporal quadrant. Radial and combined varix showed no quadrantic predilection.**Orientation:** Most common varix orientation was radial (*n* = 16/28, 57.1%), followed by circumferential varices (*n* = 6/28, 21.4%). Radial and circumferential varices (same eye but different quadrants) were also seen (*n* = 1/28, 3.6%).

In consideration of the multiple varix characteristics, the most common presentation was unilateral, radial, and inferotemporal (*n* = 7/28, 25%). Second most common presentation was unilateral, circumferential, and inferotemporal (*n* = 4/28, 14.3%).

An iris nevus was seen in 10.7% (*n* = 3/28) eyes. Of these nevi, 3.6% (*n* = 1/28) were in the primary meridian of the varix \[[Fig. 1d](#F1){ref-type="fig"}\] and 7.1% (*n* = 2/28) were in the quadrant of the varix \[[Fig. 1e](#F1){ref-type="fig"}\]. A dilated episcleral sentinel blood vessel was present in 35.7% (*n* = 10/28) in the quadrant of the varix \[[Fig. 1f](#F1){ref-type="fig"}\]. Gonioscopy revealed bridging vessels in 7.1% (*n* = 2/28), focal angle closure in the primary meridian of the varix 3.6% (*n* = 1/28) eyes, and glaucoma-related pigment dispersion in 3.6% (*n* = 1/28).

High-frequency ultrasound imaging {#sec2-7}
---------------------------------

The iris involved by varix was most commonly within than the normative range for thickness (*n* = 15/28, 53.6%). However, increased iris stromal thickness (*n* = 13/28, 46.4%) was seen and iris nodularity was noted (*n* = 12/28, 42.9%). Among all 28 iris varices, the mean (±SD) meridional iris thickness was 0.8 ± 0.1 mm (median 0.7, range 0.6--1.0 mm). Further, the ciliary body thickness in the meridian of the varix was a normative 1.3 ± 0.2 mm (median 1.3, range 1.1--1.7 mm). Additional ultrasonographic characteristics associated with the iris varices included presence of distinct, varix-related, echolucent, dot-shaped vascular channels in 14.3% (*n* = 4/28) eyes. The underlying IPE was eroded (*n* = 1/28, 3.6%), anteriorly displaced (*n* = 1/28, 3.6%), irregular and wavy (*n* = 2/28, 7.1%), and showed posterior bowing (*n* = 3/28, 10.7%) without discontinuity \[[Fig. 2](#F2){ref-type="fig"}\]. No case in our series had iridociliary angle blunting or prominent vascular channels within the adjacent ciliary body \[[Table 3](#T3){ref-type="table"}\].

![High-frequency ultrasound images (longitudinal sections): (a) varix with increased iris thickness (0.8 mm), (b) prominent hypoechoiec spot signifies a vascular channel (yellow-arrow), (c) zoomed-in view: nodular iris stroma with multiple dot-like and linear hypo-echoic vascular channels (red arrows), and (d) focal angle narrowing (red arrow) with posterior bowing of iris pigment epithelium (yellow arrow)](IJO-67-350-g002){#F2}

###### 

High-frequency ultrasound findings

  Eye no.   IPE                            Maximum iris thickness (varix meridian; mm)   Iris module                     Iris vascular channel                 Maximum ciliary body thickness (varix meridian; mm)
  --------- ------------------------------ --------------------------------------------- ------------------------------- ------------------------------------- -----------------------------------------------------
  1         Intact                         0.8                                           \+                              None                                  1.1
  2         Posterior bowing               0.8                                           \+                              None                                  1.2
  3         Posterior bowing               0.7                                           \+                              None                                  1.2
  4         Intact                         0.9                                           \+                              None                                  1.5
  5         Irregular                      0.9                                           \+                              None                                  1.2
  6         Intact                         0.7                                           \+                              None                                  1.4
  7         Intact                         0.7                                           None                            None                                  1.3
  8         Intact                         0.8                                           None                            \+                                    1.4
  9         Intact                         0.7                                           None                            None                                  1.5
  10        Irregular                      0.8                                           None                            \+                                    1.3
  11        Intact                         0.7                                           None                            \+                                    1.6
  12        Intact                         0.8                                           \+                              None                                  1.7
  13        Intact                         0.7                                           None                            None                                  1.3
  14        Intact                         0.6                                           None                            None                                  1.2
  15        Intact                         0.7                                           None                            None                                  1.5
  16        Intact                         0.7                                           None                            None                                  1.2
  17        Erosion                        0.8                                           \+                              None                                  1.3
  18        Posterior bowing               0.8                                           \+                              None                                  1.4
  19        Intact                         0.8                                           \+                              None                                  1.5
  20        Intact                         0.7                                           None                            \+                                    1.4
  21        Intact                         0.6                                           None                            None                                  1.3
  22        Intact                         1.0                                           None                            None                                  1.5
  23        Intact                         0.7                                           None                            None                                  1.2
  24        Anterior displacement          1.0                                           \+                              None                                  1.3
  25        Intact                         0.7                                           None                            None                                  1.1
  26        Intact                         0.7                                           None                            None                                  1.2
  27        Intact                         0.7                                           None                            None                                  1.3
  28        Intact                         1.0                                           \+                              None                                  1.5
            IPE erosion: 3.6% (*n*=1/28)   Mean: 0.8 Median: 0.7                         Nodularity: 42.9% (*n*=12/28)   Vascular channels: 14.3% (*n*=4/28)   Mean: 1.3 Median: 1.3

IPE: Iris pigment epithelium

Iris varix angiography {#sec2-8}
----------------------

Fluorescein iris angiography was not routinely performed. In two cases, it showed early hyperfluorescence, which persisted up to 10 min \[[Video clip 1](#SD1){ref-type="supplementary-material"}\]. However, no leakage of the dye into the anterior chamber was noted \[[Fig. 3](#F3){ref-type="fig"}\].

![(a) Photograph of a circumferential iris varix. (b) Gonioscopic photography revealed no extension to the ciliary body. Note no bridging vessels or pigment dispersion. (c) Iris fluorescein angiography (40 s) showed a dilated hyperfluorescent vessel with no leakage. (d) Iris fluorescein angiography (5 min) showed persistent hyperfluorescence without leakage](IJO-67-350-g003){#F3}

Follow-up and outcomes {#sec2-9}
----------------------

All patients were managed by observation. At a mean (±SD), follow-up of 37.7 ± 34.9 months (median 28, range 3--129 months), 27 eyes (96.4%) had stable varix, and 1 eye (3.6%) showed regression. No secondary iris or ciliary body melanomas evolved in this series.

Discussion {#sec1-4}
==========

This is the first long-term observational case series of eyes with iris varix. Multiple unique clinical and imaging findings were revealed. These included that varices were 92.3% unilateral and that bilateral cases occurred. Varices were most commonly located in the inferotemporal quadrant (*n* = 21/28, 75%) and radial (*n* = 16/28, 57%) in orientation. More than one variceal vein was noted in (*n* = 10/28, 36%) eyes. A single single synchronous iris nevus was seen in (*n* = 3/28, 11%). Though dilated episcleral sentinel blood vessels were seen (*n* = 10/28, 36%), high-frequency ultrasound imaging revealed no evidence of ciliary body tumor. High-frequency ultrasound findings included slightly increased iris stromal thickness in 46%, nodularity in 43% eyes, cross-sectional dot-like vascular channels in 14% eyes, and one focally eroded IPE. This patient had no additional suspicious clinical or imaging findings and remained stable over a 37-month follow-up. In our series, all varices monitored with serial ultrasonographic imaging remained stable throughout follow-up.

Though limited to two cases, iris fluorescein angiography revealed no dye leakage. At a mean follow-up of 38 months, 96% of varices were stable and one showed regression. No secondary iris or ciliary body melanomas occurred.

Previously, only isolated, unilateral cases of iris varix have been published with no associated ocular or systemic medical problems. Like our study, prior iris varices have not been associated with permanent loss of vision. Unlike our study, descriptions have not highlighted quadrantic predilection, sentinel blood vessels, or ultrasonographic characteristics \[[Table 4](#T4){ref-type="table"}\].

###### 

Review of literature on iris varix

  Publication                                                                                                          No. of eyes   Year of study   Visual acuity   Location (iris quadrant)       Mode of diagnosis   Management
  -------------------------------------------------------------------------------------------------------------------- ------------- --------------- --------------- ------------------------------ ------------------- ------------------------
  Varix of the Iris\[[@ref10]\]                                                                                        1             1975            --              Inferonasal                    Pathology           Sector iridectomy
  Varix node of the iris with spontaneous regression\[[@ref11]\]                                                       1             1992            --              Temporal                       Clinical            Observation
  Varicose vein of the iris\[[@ref12]\]                                                                                1             1995            --              Superonasal                    Pathology           Sector iridectomy
  Iris varix\[[@ref13]\]                                                                                               1             1997            6/6             Inferotemporal                 Pathology           Sector iridectomy
  Iris varix simulating an iris melanoma\[[@ref14]\]                                                                   1             2000            6/6             Inferonasal                    Pathology           Sector iridectomy
  Iris varix: report of a case and review of iris vascular anomalies\[[@ref9]\]                                        1             2009            20/20           Superonasal                    Pathology           Excision
  Unilateral tumor of the iris\[[@ref15]\]                                                                             1             2011            20/20           Temporal                       Clinical            Observation
  Iris varix as a cause of late-onset inflammation after implantation of a phakic iris claw lens\[[@ref16]\]           1             2012            20/20           Superotemporal                 Clinical            Observation
  Successful argon and diode laser photocoagulation treatment of an iris varix with recurrent hemorrhage\[[@ref17]\]   1             2013            20/20           Superotemporal                 Clinical            Laser photocoagulation
  Our study                                                                                                            28            2018            20/20 (mean)    Inferotemporal (most common)   Clinical            Observation

M: Male; F: Female

All the aforementioned cases suggest that iris varix is an acquired condition. The youngest reported case was of a 31-year-old male by Ang *et al.*\[[@ref13]\] In our series, the median patient age was 57.5, range 37--81 years. Six of the nine varix-reported cases were male and we also found a slight male preponderance (male-to-female of 1:1.36).\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\]

In contrast to prior studies where ultrasonographic findings have included irregular, echo-dense mass in the iris stroma, in our study, iris varices have been shown to be moderately reflective mass, dotted with echolucent varix-related ultrasonographic cross-sections.\[[@ref9][@ref14]\] Though the involved iris stroma was marginally thickened, benign findings included a general respect for tissue planes (IPE and ciliary body).

Fluorescein iris angiography has been reported. Broaddus *et al.* described a varix to be a hypo-fluorescent mass, whereas Kuchle *et al.* found a well-circumscribed hyperfluorescence with surrounding hypofluorescence.\[[@ref9][@ref11]\] However, in our series, we noted early hyperfluorescence without any leakage of the dye indicating that the anomalous varix contains an intact vascular endothelium and thus blood--aqueous barrier.

Iris varix is most often confused with iris hemangioma. More than half of the iris varix cases till date have been histopathologically diagnosed \[[Table 4](#T4){ref-type="table"}\].\[[@ref9][@ref10][@ref12][@ref13][@ref14]\] Iris hemangiomas tend to be lobulated, bleed recurrently into the anterior chamber, and leak dye on fluorescein iris angiography.\[[@ref9]\] In addition, iris varix has been presumed as a clinical pointer to a forme-fruste iris melanoma or irido-ciliary melanoma.\[[@ref14]\] The presence of pupillary dysmorphism, episcleral sentinel blood vessel, erosion of IPE, and dye leakage can be used to clinically distinguish between iris melanoma and varix \[[Table 5](#T5){ref-type="table"}\]. The main limitation of our study was the retrospective nature and lack of pathological confirmation.

###### 

Comparison of common features in the differential diagnoses of iris varix

  Features                                   Iris varix       Iris hemangioma       Iris melanoma
  ------------------------------------------ ---------------- --------------------- ---------------------------------
  Hyphema                                    Rare             Common                Rare
  Corectopia                                 Rare             Rare                  Common
  Ectropion uveae                            Rare             Rare                  Common
  Episcleral sentinel vessel                 Rare             Rare                  Common
  Bridging vessels on gonioscopy             Rare             Rare                  Common
  Pigment dispersion on gonioscopy           Rare             Rare                  Typical
  IPE on high-frequency ultrasound imaging   Intact           Intact                Eroded
  Iris FA                                    No dye leakage   Dye leakage present   Dye leakage with feeder vessels

IPE: Iris pigment epithelium; FA: Fluorescein angiography

Conclusion {#sec1-5}
==========

This long-term observational study of iris varix reveals it to be a benign vasculopathy without associated morbidity or risk of secondary malignant transformation.

Financial support and sponsorship {#sec2-10}
---------------------------------

The study was financially supported by Eye Cancer Foundation, New York, USA (<http://eyecancerfoundation.net>). Dr. Puneet Jain received a fellowship grant from the foundation.

Conflicts of interest {#sec2-11}
---------------------

There are no conflicts of interest.

Video Available on: [www.ijo.in](www.ijo.in)
============================================
